Pharma: Novo Nordisk's Wegovy pill launch has significantly increased patient interest in GLP-1 weight loss treatments.
CNBC chatted with five U.S. patients who recently began taking the new pill after its launch. Their experiences so far have been quite different, showcasing a range of initial reactions. Stay tuned for their insights! #HealthNews #PatientStories
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
